FDA Approves 1st mRNA Flu Vaccine
Digest more
The FDA has approved a new seasonal fly vaccine from Moderna called mFLUSIVA.
Moderna began a Phase 1 clinical trial of its experimental vaccine mRNA-1469 targeting the Bundibugyo strain of Ebola virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results